Cargando…
HbA1c and FIB-4 as serologic markers for the risk of progression of stage A heart failure
The use of glycosylated hemoglobin as a diabetic glycemic control and cardiovascular risk marker is well documented. It has also been suggested as a marker for early diastolic hemodynamic changes leading to clinical heart failure, but is less well characterized. This study explored the association b...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Magdi Yacoub Heart Foundation
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491392/ https://www.ncbi.nlm.nih.gov/pubmed/36185157 http://dx.doi.org/10.21542/gcsp.2021.25 |